Are we closing in on an "elusive enemy"? The current status of our battle with Acinetobacter baumannii

Virulence. 2011 Mar-Apr;2(2):86-90. doi: 10.4161/viru.2.2.15748.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Comment

MeSH terms

  • Acinetobacter Infections / drug therapy*
  • Acinetobacter Infections / epidemiology
  • Acinetobacter Infections / microbiology*
  • Acinetobacter baumannii / drug effects*
  • Acinetobacter baumannii / pathogenicity
  • Anti-Bacterial Agents / pharmacology*
  • Cross Infection / drug therapy*
  • Cross Infection / epidemiology
  • Cross Infection / microbiology*
  • Drug Resistance, Multiple, Bacterial*
  • Humans

Substances

  • Anti-Bacterial Agents